Canagliflozin regulates metabolic reprogramming in diabetic kidney disease by inducing fasting-like and aestivation-like metabolic patterns
Conclusions/interpretationIn conclusion, our study shows that CANA ameliorates DKD by inducing fasting-like and aestivation-like metabolic patterns. Furthermore, DKD was ameliorated by glycine supplementation, and the beneficial effects of glycine were probably due to the activation of the AMPK/mTOR pathway.Graphical Abstract
Source: Diabetologia - Category: Endocrinology Source Type: research
More News: Canagliflozin | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Insulin | Invokana | SGLT2 Inhibitors | Study | Sugar | Urology & Nephrology | Women